A detailed history of Northern Trust Corp transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 112,216 shares of ACET stock, worth $111,093. This represents 0.0% of its overall portfolio holdings.

Number of Shares
112,216
Previous 402,541 72.12%
Holding current value
$111,093
Previous $487,000 66.94%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.07 - $1.63 $310,647 - $473,229
-290,325 Reduced 72.12%
112,216 $161,000
Q2 2024

Aug 14, 2024

SELL
$1.21 - $2.4 $40,019 - $79,377
-33,074 Reduced 7.59%
402,541 $487,000
Q1 2024

May 14, 2024

BUY
$1.76 - $3.45 $358,212 - $702,178
203,530 Added 87.7%
435,615 $1.02 Million
Q4 2023

Feb 13, 2024

BUY
$1.11 - $1.89 $1,869 - $3,182
1,684 Added 0.73%
232,085 $438,000
Q3 2023

Nov 13, 2023

SELL
$1.37 - $3.4 $15,889 - $39,433
-11,598 Reduced 4.79%
230,401 $315,000
Q2 2023

Aug 11, 2023

SELL
$2.13 - $7.13 $43,522 - $145,687
-20,433 Reduced 7.79%
241,999 $588,000
Q1 2023

May 15, 2023

SELL
$5.52 - $9.23 $22,284 - $37,261
-4,037 Reduced 1.51%
262,432 $1.51 Million
Q4 2022

Feb 13, 2023

BUY
$7.72 - $21.27 $196,643 - $541,789
25,472 Added 10.57%
266,469 $2.38 Million
Q3 2022

Nov 14, 2022

BUY
$13.43 - $18.74 $231,492 - $323,021
17,237 Added 7.7%
240,997 $3.43 Million
Q2 2022

Aug 12, 2022

BUY
$10.26 - $20.81 $200,685 - $407,043
19,560 Added 9.58%
223,760 $3.27 Million
Q1 2022

May 13, 2022

BUY
$11.53 - $19.97 $399,502 - $691,940
34,649 Added 20.44%
204,200 $4.08 Million
Q4 2021

Feb 08, 2022

SELL
$7.37 - $17.49 $26,885 - $63,803
-3,648 Reduced 2.11%
169,551 $2.97 Million
Q3 2021

Nov 15, 2021

SELL
$6.29 - $9.93 $62,541 - $98,733
-9,943 Reduced 5.43%
173,199 $1.36 Million
Q2 2021

Aug 13, 2021

BUY
$9.19 - $15.93 $1.44 Million - $2.5 Million
157,156 Added 604.77%
183,142 $1.89 Million
Q1 2021

May 12, 2021

BUY
$12.12 - $17.17 $314,950 - $446,179
25,986 New
25,986 $340,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $39.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.